# LB Pharmaceuticals

LB Pharmaceuticals is an Asset Manager.

## Overview

- **Organization type:** Asset Manager
- **Assets under management:** Undisclosed
- **Website:** lbpharma.com
- **LinkedIn:** https://www.linkedin.com/company/lbpharma

## Regulatory record

- **Reports private funds:** No

## About

Developing novel therapies for neuropsychiatric diseases | LB Pharmaceuticals is a clinical-stage biopharmaceutical company dedicated to transforming the treatment of schizophrenia.

## Sectors

- Healthcare Services

## Questions

### What is LB Pharmaceuticals' lead drug candidate?

The firm is developing a transdermal patch formulation of risperidone for once-weekly administration. Risperidone is a generic atypical antipsychotic used widely in schizophrenia and bipolar disorder. The patch is designed to maintain steady plasma levels and provide a visual adherence check for caregivers.

### What regulatory pathway is LB Pharmaceuticals using?

The company is pursuing approval through the FDA's 505(b)(2) pathway, which lets sponsors reference published literature and the agency's prior findings for the active ingredient rather than conducting a full de novo clinical program. This reduces development time and cost relative to a new chemical entity.

### What challenges does the transdermal patch address?

Schizophrenia relapse is overwhelmingly driven by medication non-adherence, which can exceed 50% within the first year of oral therapy. A weekly patch that caregivers can visually confirm has been applied directly addresses the adherence gap that oral tablets and self-administered regimens cannot solve.

## Related profiles

- [Petco Health & Wellness Company](https://altss.com/profile/petco-health-and-wellness-company-inc)
- [Employers Holdings](https://altss.com/profile/employers-holdings-inc)

---

Last updated: 2026-06-03T20:00:00.000Z

Canonical page: https://altss.com/profile/lb-pharmaceuticals-inc

Maintained by Altss — https://altss.com — methodology: https://altss.com/methodology